|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT01212393 |
|
Date of registration:
|
29/09/2010 |
|
Primary sponsor: |
|
|
Public title:
|
Prevention of Venous Thromboembolism Disease in Emergency Departments
PREVENU |
|
Scientific title:
|
Prevention of Venous Thromboembolism Disease for Acutelly Ill Medical Patients Admitted to Hospital : Systematic Analysis of Thrombosis Risk Factors and Remember of Prevention Treatment Indications in Emergency Departments. |
|
Date of first enrolment:
|
September 2009 |
|
Target sample size:
|
18000 |
|
Recruitment status: |
Recruiting |
|
URL:
|
http://clinicaltrials.gov/show/NCT01212393 |
|
Study type:
|
Observational |
|
Study design:
|
Time Perspective: Prospective
|
|
|
Countries of recruitment
|
|
France
| | | | | | | |
|
Contacts
|
|
Name:
|
Pierre-Marie ROY, MD |
|
Address:
|
|
|
Telephone:
|
00-2-41-35-37-18 |
|
Email:
|
pmroy@chu-angers.fr |
|
Affiliation:
|
|
|
|
Name:
|
Pierre-Marie ROY, MD, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
UH Angers |
| |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- age over 40 years
- Emergency department admission for non-traumatic reason
- Hospitalization in medical setting
Exclusion Criteria:
- patients less than 40 years old
- patients hospitalized in a facility which doesn't participate to the study
- 3 months follow-up not possible
- patients refusing that their personal data are used for medical research
- patients refusing to be reach for the 3 months follow-up
Age minimum:
40 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Quality of Health Care
|
|
Intervention(s)
|
|
Behavioral: reminders
|
|
Primary Outcome(s)
|
|
Symptomatic venous thromboembolic events and severe haemorrhage
[Time Frame: 3 months]
|
|
Secondary Outcome(s)
|
|
appropriateness of thromboprophylaxis
[Time Frame: 3 months]
|
|
rate of severe haemorrhage
[Time Frame: 3 months]
|
|
Rate of symptomatic venous thromboembolic events
[Time Frame: 3 months]
|
|
Rate of thromboembolic events
[Time Frame: 3 months]
|
|
Secondary ID(s)
|
|
PHRC 2008-02
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|